179 related articles for article (PubMed ID: 24244422)
21. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
[TBL] [Abstract][Full Text] [Related]
22. Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens.
Gonsky R; Deem RL; Landers CJ; Derkowski CA; Berel D; McGovern DP; Targan SR
Inflamm Bowel Dis; 2011 Jan; 17(1):171-8. PubMed ID: 20848535
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation of TH1/TH2 cytokine genes affects sensitization and progress of experimental asthma.
Brand S; Kesper DA; Teich R; Kilic-Niebergall E; Pinkenburg O; Bothur E; Lohoff M; Garn H; Pfefferle PI; Renz H
J Allergy Clin Immunol; 2012 Jun; 129(6):1602-10.e6. PubMed ID: 22277202
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
25. Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis.
Sun Z; Liu G; Xu N
Thorac Cancer; 2019 Jan; 10(1):54-59. PubMed ID: 30390382
[TBL] [Abstract][Full Text] [Related]
26. The regulation of TIM-3 transcription in T cells involves c-Jun binding but not CpG methylation at the TIM-3 promoter.
Yun SJ; Jun KJ; Komori K; Lee MJ; Kwon MH; Chwae YJ; Kim K; Shin HJ; Park S
Mol Immunol; 2016 Jul; 75():60-8. PubMed ID: 27243212
[TBL] [Abstract][Full Text] [Related]
27. Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
Tsuji T; Altorki NK; Ritter G; Old LJ; Gnjatic S
J Immunol; 2009 Oct; 183(7):4800-8. PubMed ID: 19734225
[TBL] [Abstract][Full Text] [Related]
28. X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells.
Ma S; Zhang WL; Leckey BD; Xu HT; Yang LH; Wang E
J Exp Clin Cancer Res; 2018 Dec; 37(1):315. PubMed ID: 30547821
[TBL] [Abstract][Full Text] [Related]
29. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H
Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666
[TBL] [Abstract][Full Text] [Related]
30. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.
Tang X; Khuri FR; Lee JJ; Kemp BL; Liu D; Hong WK; Mao L
J Natl Cancer Inst; 2000 Sep; 92(18):1511-6. PubMed ID: 10995806
[TBL] [Abstract][Full Text] [Related]
31. Methylation pattern of IFNG in periapical granulomas and radicular cysts.
Campos K; Gomes CC; de Fátima Correia-Silva J; Farias LC; Fonseca-Silva T; Bernardes VF; Pereira CM; Gomez RS
J Endod; 2013 Apr; 39(4):493-6. PubMed ID: 23522543
[TBL] [Abstract][Full Text] [Related]
32. DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis.
Wang YY; Wang Q; Sun XH; Liu RZ; Shu Y; Kanekura T; Huang JH; Li YP; Wang JC; Zhao M; Lu QJ; Xiao R
Br J Dermatol; 2014 Jul; 171(1):39-47. PubMed ID: 24641670
[TBL] [Abstract][Full Text] [Related]
33. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
35. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
36. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
[TBL] [Abstract][Full Text] [Related]
38. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
Kim YT; Lee SH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
[TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.
Pastuszak-Lewandoska D; Kordiak J; Migdalska-Sęk M; Czarnecka KH; Antczak A; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska D; Brzeziańska-Lasota E
Respir Res; 2015 Jun; 16(1):76. PubMed ID: 26112163
[TBL] [Abstract][Full Text] [Related]
40. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.
Kang N; Choi SY; Kim YK; Yoo IeR; Han DH; Lee DS; Kim YS; Hong SH; Kang JH; Lee KY; Park JK; Sung SW; Park MS; Yim HW; Kim SJ; Park JY
Lung Cancer; 2015 Aug; 89(2):99-103. PubMed ID: 26101014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
